Key Insights

Highlights

Treatment Research

2 treatments under study, led by Intact Cows Milk Protein Formula

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Not Yet Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07449507Not ApplicableNot Yet RecruitingPrimary

Partially Hydrolyzed Whey Protein Formula for Infants With Mild Allergy

Showing all 1 trials

Research Network

Common Treatments

  • Intact Cows Milk Protein Formula1
  • Partially Hydrolyzed Whey Protein Formula1

Active Sponsors

  • Chengdu Women's and Children's Central Hospital1
  • Zhengzhou Children's Hospital, China1
  • Ruijin Hospital1
  • Wuhan Children's Hospital1

Related Conditions

  • Infant Feeding Intolerance1

Activity Timeline